Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing protein 3A (PRELID3A) is a mitochondrial lipid transfer protein that enables the transfer of phosphatidic acid (PA) between membranes, particularly across the mitochondrial intermembrane space[1][3][4][5][10]. By forming a complex with the partner protein TRIAP1, PRELID3A facilitates the critical import of phosphatidic acid required for cardiolipin synthesis in the mitochondrial inner membrane[4][8]. Structural studies demonstrate that the PRELI domain forms a lipid-binding cavity that is essential for regulated lipid transfer[2][6]. PRELID3A localizes to the mitochondria and is essential for maintaining mitochondrial membrane structure and integrity through its role in phospholipid transport[2][4][8][10]. No direct information on clinically approved drugs, disease biomarker roles, or known safety concerns is available in current references; PRELID3A is primarily a fundamental component of mitochondrial lipid metabolism rather than a conventional therapeutic target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing protein 3A (PRELID3A).